News for STAA Stock

STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors STAAR Surgical Announces $30 Million Share Repurchase Authorization STAAR Surgical Reports First Quarter 2025 Results STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025 STAAR Surgical Announces Realignment of Leadership Structure STAAR Surgical Announces Leadership Transition STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025 STAAR Surgical to Participate in BTIG Ophthalmology Day STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024) CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results STAAR Surgical Reports Third Quarter 2024 Results STAAR Surgical to Report Third Quarter Results on October 30, 2024 STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand STAAR Surgical Reports Second Quarter 2024 Results STAAR Surgical to Report Second Quarter Results on August 7, 2024 STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference STAAR Surgical Reports First Quarter 2024 Results STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel STAAR Surgical to Report First Quarter Results on May 7, 2024 STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024 STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024 STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors STAAR Surgical to Participate in Two Upcoming Investor Conferences STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results STAAR Surgical to Report Fourth Quarter Results on February 26, 2024 STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023 Lilian Zhou Appointed to STAAR Surgical Board of Directors STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023) STAAR Surgical Reports Third Quarter 2023 Results STAAR Surgical to Report Third Quarter Results on November 1, 2023 STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL) Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023 STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023 STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL STAAR Surgical to Participate in Upcoming Investor Conferences STAAR Surgical Reports Second Quarter 2023 Results STAAR Surgical to Report Second Quarter Results on August 2, 2023 EVO ICL Sponsors Jonas Brothers’ The Tour STAAR Surgical Reports First Quarter 2023 Results STAAR Surgical to Report First Quarter Results on May 3, 2023 STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023 Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022 STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO STAAR Surgical Opens EVO Experience Center in United States STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y STAAR Surgical to Report Third Quarter Results on November 2, 2022 Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses STAAR Surgical Patient Awareness Campaign Launched In New York STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y STAAR Surgical to Report Second Quarter Results on August 10, 2022 STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL) STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y STAAR Surgical to Report First Quarter Results on May 4, 2022 STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S. STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022 STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y STAAR Surgical to Report Third Quarter Results on November 3, 2021 STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021 STAAR Surgical to Report Second Quarter Results on August 4, 2021 STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y STAAR Surgical to Report First Quarter Results on May 5, 2021 STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021 Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results STAAR Surgical Begins Commercialization of EVO Viva™ Presbyopia Correcting Lens STAAR Surgical Reports Third Quarter 2020 Results STAAR Surgical to Report Third Quarter Results on November 4, 2020